Literature DB >> 1727768

Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').

M N Marsh1.   

Abstract

This article examines associations between gluten, polymorphisms of the major histocompatibility complex, and mucosal pathology representative of the spectrum of gluten sensitivity. Sequences of wheat, rye, and barley prolamins contain recurring tetrapeptide motifs that are predicted to have beta-reverse-turn secondary structure and that, with in vitro assays, appear active. Structural polymorphisms of major histocompatibility complex subloci identify codon switches within the second exon that control the third hypervariable region in the outer domain of the beta chain. Observations of the intestinal response to gluten reveal five interrelated lesions (preinfiltrative, infiltrative, hyperplastic, destructive, and hypoplastic) that are interpretable as cell-mediated immunologic responses. These responses originate in the lamina propria, where a series of antigen-specific inflammatory processes has now been identified. There is no evidence that celiac sprue is a disease of jejunal enterocytes. Furthermore, the role of intraepithelial space lymphocytes in pathogenesis, if relevant, needs further experimental dissection. Also awaiting further definition are polymorphisms of the celiac lymphocyte antigen receptor and their relationship to gliadin oligopeptide(s) and predisposing genes. The nature and basis of nonresponsive celiac sprue require more thoughtful initiatives to elucidate the immunologic mechanism(s) of unresponsiveness and evaluate possible means of reversal. Finally, a more sensible definition of gluten sensitivity (unhampered by qualitative morphological imagery) is ultimately called for in order to accommodate the biomolecular advances addressed in this review.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727768

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  477 in total

1.  Relative power of linkage and transmission disequilibrium test strategies to detect non-HLA linked coeliac disease susceptibility genes.

Authors:  S Bevan; S Popat; R S Houlston
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Contribution of the MHC region to the familial risk of coeliac disease.

Authors:  S Bevan; S Popat; C P Braegger; A Busch; D O'Donoghue; K Falth-Magnusson; A Ferguson; A Godkin; L Hogberg; G Holmes; K B Hosie; P D Howdle; H Jenkins; D Jewell; S Johnston; N P Kennedy; G Kerr; P Kumar; R F Logan; A H Love; M Marsh; C J Mulder; K Sjoberg; L Stenhammer; J Walker-Smith; A M Marossy; R S Houlston
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

Review 3.  Nongranulomatous chronic idiopathic enterocolitis: a primary histologically defined disease.

Authors:  K H Soergel
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

4.  Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study.

Authors:  J A Murray; J Herlein; F Mitros; J A Goeken
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

5.  Diagnostic approach to a patient with suspected celiac disease: a cost analysis.

Authors:  G C Harewood; J A Murray
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

6.  Increased risk of surgery in undiagnosed celiac disease.

Authors:  C Ciacci; R Cavallaro; R Romano; D S Galletta; F Labanca; M Marino; M Donisi; G Mazzacca
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

Review 7.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 8.  Genetic factors underlying gluten-sensitive enteropathy.

Authors:  A S Peña; C Wijmenga
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

9.  Stroke and dilated cardiomyopathy associated with celiac disease.

Authors:  Murat Doğan; Erdal Peker; Eren Cagan; Sinan Akbayram; Mehmet Acikgoz; Huseyin Caksen; Abdurrahman Uner; Yasar Cesur
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

10.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.